GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AIM Vaccine Co Ltd (HKSE:06660) » Definitions » Earnings per Share (Diluted)

AIM Vaccine Co (HKSE:06660) Earnings per Share (Diluted) : HK$-0.25 (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is AIM Vaccine Co Earnings per Share (Diluted)?

AIM Vaccine Co's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was HK$-0.13. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.25.

AIM Vaccine Co's EPS (Basic) for the six months ended in Dec. 2024 was HK$-0.13. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.25.

AIM Vaccine Co's EPS without NRI for the six months ended in Dec. 2024 was HK$-0.11. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.23.

During the past 12 months, AIM Vaccine Co's average EPS without NRIGrowth Rate was -1161.90% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 31.60% per year.

During the past 6 years, AIM Vaccine Co's highest 3-Year average EPS without NRI Growth Rate was 31.60% per year. The lowest was -61.70% per year. And the median was -15.05% per year.


AIM Vaccine Co Earnings per Share (Diluted) Historical Data

The historical data trend for AIM Vaccine Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AIM Vaccine Co Earnings per Share (Diluted) Chart

AIM Vaccine Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Earnings per Share (Diluted)
Get a 7-Day Free Trial 0.37 -0.70 -0.30 -1.17 -0.25

AIM Vaccine Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only -0.25 -0.23 -0.94 -0.12 -0.13

Competitive Comparison of AIM Vaccine Co's Earnings per Share (Diluted)

For the Biotechnology subindustry, AIM Vaccine Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AIM Vaccine Co's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AIM Vaccine Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where AIM Vaccine Co's PE Ratio falls into.


;
;

AIM Vaccine Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

AIM Vaccine Co's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-295.995-0)/1211.063
=-0.24

AIM Vaccine Co's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (Q: Dec. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-147.317-0)/1211.063
=-0.12

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


AIM Vaccine Co  (HKSE:06660) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


AIM Vaccine Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of AIM Vaccine Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


AIM Vaccine Co Business Description

Traded in Other Exchanges
N/A
Address
2 Ronghua South Road, 26th Floor, Building T6, Han’s Plaza, Economic Technological Development Area, Beijing, CHN
AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain, ranging from research and development to manufacturing and commercialization. The Vaccine products include Recombinant HBV Vaccines, Freeze-dried Human Rabies Vaccine, Inactivated HAV Vaccines, Group A, C, Y, and W135 MPSV, Bivalent Inactivated HFRS Vaccine, and Mumps Vaccine. It generates the majority of its revenues in the PRC.
Executives
Shang Hai Xun Jing Qi Ye Guan Li Zhong Xin You Xian He Huo 2201 Interest of corporation controlled by you
Xi Zang Ying Feng Shi Ye You Xian Gong Si 2101 Beneficial owner
Yang Aihua 2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Shang Yin Xing Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Shi Bei Lun Qu Guo You Zi Ben Yun Ying You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Kong Gu You Xian Gong Si 2101 Beneficial owner
Chang Wei 2201 Interest of corporation controlled by you
Wang Aijun 2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd. 2201 Interest of corporation controlled by you
Zhang Kuo 2201 Interest of corporation controlled by you
Zhang Chong 2201 Interest of corporation controlled by you

AIM Vaccine Co Headlines

No Headlines